4//SEC Filing
Dastoor Firdaus J. 4
Accession 0001662252-17-000232
CIK 0001534525other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 5:39 PM ET
Size
13.7 KB
Accession
0001662252-17-000232
Insider Transaction Report
Form 4
Dastoor Firdaus J.
Director
Transactions
- Award
Stock Option
2017-11-15+25,000→ 25,000 totalExercise: $2.18Exp: 2027-11-15→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]On November 15, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its Amended and Restated 2014 Equity Incentive Plan (the "Plan"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on November 15, 2017 of $2.18. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date.
Documents
Issuer
Xenetic Biosciences, Inc.
CIK 0001534525
Entity typeother
Related Parties
1- filerCIK 0001690576
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 5:39 PM ET
- Size
- 13.7 KB